Mundipharma Healthcare Indonesia Appoints Pyridam Farma to Market Betadine Brand in Indonesia
Jakarta, April 5, 2022 – Mundipharma Healthcare Indonesia (MHI), the owner of the Betadine brand in Indonesia, has signed an exclusive cooperation agreement for marketing and promotion services with PT Pyridam Farma Tbk, a public pharmaceutical company in Indonesia with the issuer code PYFA.
The collaboration is forged by building synergies between the two companies to strengthen the Betadine market in hospitals, health institutions, and health offices. This synergy was built to expand access and availability of Betadine products on the channel as a form of commitment from the two companies to provide the best products and services for the Indonesian people.
Lee Yan Gwan as CEO of Pyridam Farma said that “We are very happy and grateful for the trust of Mundipharma Healthcare Indonesia to collaborate with Pyridam Farma. In addition to expanding the marketing of Betadine products, this collaboration is also in line with Pyridam Farma’s vision to advance the healthcare industry in Indonesia. Indonesia. So we hope that we can help facilitate the access of Indonesian people to obtain Betadine products.”
Country Lead of Mundipharma Healthcare Indonesia, Handaka, added
“This exclusive partnership with Pyridam Farma is made as a form of Mundipharma Indonesia’s dedication in providing good services and products for the wider community.”
Betadine itself is an antiseptic product that has been trusted by the public and public healthcare professionals around the world for almost 50 years. In 2021, Betadine was named the Top Brand for the category of wound medicine, wound plaster, and mouthwash. (source: Top Brand Index from Top Brand Awards).
Pyridam Farma is committed to continuously providing the best products for the Indonesian people and together with Mundipharma Healthcare Indonesia, Pyridam Farma believes that by presenting high quality products, it can advance the Indonesian healthcare industry while creating a healthier life.
We are Mundipharma, a place where caring and collaboration meet, to make a difference when it matters most. Mundipharma is a global healthcare company with a presence in Africa, Asia Pacific, Canada, Europe, Latin America and the Middle East.
Mundipharma is dedicated to providing innovative care to patients in the areas of Pain Management, Infectious Diseases and Consumer Health Care as well as other areas of severe and debilitating disease. Our guiding principles, centered on Integrity and Forbearance, are at the heart of everything we do. For more information visit www.mundipharma.com.
BETADINE® is an antiseptic product that has been trusted by the public and health professionals around the world for more than 50 years to prevent and treat infections. It started in 1969 when BETADINE® became the antiseptic used by NASA to clean Apollo 11x
In Indonesia, BETADINE® has four product categories, namely Wound Care (Wound Treatment Products), URTI Care (Products for the Mouth, Nose and Throat), Feminine Care (Products for the Female Area), Protective Care (Products for Cleaning the Body), for meet the various needs of customers to prevent and treat infections.
About PT Pyridam Farma Tbk.
PT Pyridam Farma Tbk is a pharmaceutical company whose main business is the production and/or distribution of modern and traditional medicines and the distribution of medical devices such as laboratory equipment and PCR test kits. The company was founded in 1976 and has been a public company and has been listed on the Indonesia Stock Exchange since 2001.
PT Pyridam Farma Tbk. manufactures various kinds of pharmaceutical products ranging from antibiotics, vitamins, health supplements, to traditional medicines. The company has more than 200 products in the form of effervescent tablets, caplets, capsules, syrups, and creams.
PT Pyridam Farma Tbk also provides tolling services as well as MA Holder and has partnered with more than 10 global pharmaceutical companies to provide registration services along with product marketing.